Vytrus Biotech, S.A. (BME:VYT)

Market Cap	42.14M
Revenue (ttm)	6.09M
Net Income (ttm)	1.02M
Shares Out	7.52M
EPS (ttm)	0.14
PE Ratio	41.27
Forward PE	22.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	4,127
Open	5.60
Previous Close	5.50
Day's Range	5.60 - 5.60
52-Week Range	2.10 - 6.05
Beta	0.04
RSI	64.34
Earnings Date	n/a

About Vytrus Biotech

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. The company offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a prebiotic active that stimulates the skin bacteria; Olea Vitae cellular oil for ageing; Turmeria Zen a natural active with regenerating properties for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents fr...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 37
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: VYT

Financial Performance

In 2024, Vytrus Biotech's revenue was 6.09 million, an increase of 29.51% compared to the previous year's 4.70 million. Earnings were 1.02 million, an increase of 87.36%.